Cargando…
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report
Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013649/ https://www.ncbi.nlm.nih.gov/pubmed/35301802 http://dx.doi.org/10.1111/1759-7714.14374 |
_version_ | 1784688040560558080 |
---|---|
author | Yukawa, Takuro Ishida, Yuta Naomoto, Yoshio Monobe, Yasumasa Fukazawa, Takuya Yamatsuji, Tomoki |
author_facet | Yukawa, Takuro Ishida, Yuta Naomoto, Yoshio Monobe, Yasumasa Fukazawa, Takuya Yamatsuji, Tomoki |
author_sort | Yukawa, Takuro |
collection | PubMed |
description | Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right middle lobe hypoplasia. He subsequently underwent right upper and middle lobectomy with lymph node dissection by video‐assisted thoracoscopic surgery. In addition to an invasive adenocarcinoma in the right upper lobe, pathological examination of the hypoplastic lobe revealed neuroendocrine hyperplasia, as well as tumorlets and a typical carcinoid. Eight cases of pulmonary neuroendocrine tumors that developed from pulmonary hypoplasia have been reported to date. Interestingly, all but one case occurred in the right middle lobe. Neuroendocrine cell hyperplasia has been reported to develop in hypoplastic lungs postnatally; therefore, we speculated that the lesion was the origin of these neuroendocrine tumors. Moreover, the pathological findings suggested that atelectasis was involved in the pathogenesis of this rare condition. In adults, when lobar hypoplasia is diagnosed, neuroendocrine tumors should be anticipated. |
format | Online Article Text |
id | pubmed-9013649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-90136492022-04-20 Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report Yukawa, Takuro Ishida, Yuta Naomoto, Yoshio Monobe, Yasumasa Fukazawa, Takuya Yamatsuji, Tomoki Thorac Cancer Case Reports Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70‐year‐old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right middle lobe hypoplasia. He subsequently underwent right upper and middle lobectomy with lymph node dissection by video‐assisted thoracoscopic surgery. In addition to an invasive adenocarcinoma in the right upper lobe, pathological examination of the hypoplastic lobe revealed neuroendocrine hyperplasia, as well as tumorlets and a typical carcinoid. Eight cases of pulmonary neuroendocrine tumors that developed from pulmonary hypoplasia have been reported to date. Interestingly, all but one case occurred in the right middle lobe. Neuroendocrine cell hyperplasia has been reported to develop in hypoplastic lungs postnatally; therefore, we speculated that the lesion was the origin of these neuroendocrine tumors. Moreover, the pathological findings suggested that atelectasis was involved in the pathogenesis of this rare condition. In adults, when lobar hypoplasia is diagnosed, neuroendocrine tumors should be anticipated. John Wiley & Sons Australia, Ltd 2022-03-17 2022-04 /pmc/articles/PMC9013649/ /pubmed/35301802 http://dx.doi.org/10.1111/1759-7714.14374 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Yukawa, Takuro Ishida, Yuta Naomoto, Yoshio Monobe, Yasumasa Fukazawa, Takuya Yamatsuji, Tomoki Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title | Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title_full | Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title_fullStr | Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title_full_unstemmed | Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title_short | Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report |
title_sort | neuroendocrine tumor secondary to pulmonary hypoplasia: a case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013649/ https://www.ncbi.nlm.nih.gov/pubmed/35301802 http://dx.doi.org/10.1111/1759-7714.14374 |
work_keys_str_mv | AT yukawatakuro neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport AT ishidayuta neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport AT naomotoyoshio neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport AT monobeyasumasa neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport AT fukazawatakuya neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport AT yamatsujitomoki neuroendocrinetumorsecondarytopulmonaryhypoplasiaacasereport |